New Zealand markets open in 1 hour 56 minutes

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
19.09-0.61 (-3.10%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
231,925
231,925
14,553
-
-
Gross profit
231,925
231,925
14,553
-
-
Operating expenses
Research development
26,751
26,751
12,712
9,516
7,763
Selling general and administrative
5,946
5,946
3,437
1,914
1,763
Total operating expenses
32,714
32,714
16,159
11,438
9,532
Operating income or loss
199,211
199,211
-1,606
-11,438
-9,532
Total other income/expenses net
225
225
1,389
3,595
186
Income before tax
205,140
205,140
184
-7,794
-9,193
Income tax expense
48,059
48,059
0
0
0
Income from continuing operations
157,081
157,081
184
-7,794
-9,193
Net income
157,081
157,081
184
-7,794
-9,193
Net income available to common shareholders
157,081
157,081
184
-7,794
-9,193
Basic EPS
0.44
1.24
0.00
-0.07
-0.09
Diluted EPS
0.44
1.20
0.00
-0.07
-0.09
Basic average shares
126,266
127,070
125,966
117,770
107,057
Diluted average shares
126,266
130,792
125,966
117,770
107,057